CN105663091A — 一种布地奈德肠溶缓释胶囊及其制备方法
Assigned to SHANGHAI SINE PROMD PHARMACEUTICAL CO Ltd · Expires 2016-06-15 · 10y expired
What this patent protects
本发明提供一种布地奈德肠溶缓释胶囊及其制备方法。所述胶囊内容物由下列重量百分比的成分组成:药用微丸丸芯76.0~83.0%、布地奈德0.5~1.0%、缓释材料0.6~1.3%、致孔剂0.8~1.3%、增塑剂1.0~1.5%、肠溶材料9.0~12.0%、防粘剂4.5~7.0%。本发明提供制备方法:先将布地奈德原料药经过气流粉碎机粉碎使原料药粒径高度接近,降低原料药在溶媒中的释放差异,缩小批间差异,再采用超声搅拌法,在微丸上药工序,将上药混悬液置于超声仪,使用搅拌器边搅拌边上药,使上药混悬液原料药分布均一,提高微丸含量均一性。本发明产品质量好,制备简单,宜于…
USPTO Abstract
本发明提供一种布地奈德肠溶缓释胶囊及其制备方法。所述胶囊内容物由下列重量百分比的成分组成:药用微丸丸芯76.0~83.0%、布地奈德0.5~1.0%、缓释材料0.6~1.3%、致孔剂0.8~1.3%、增塑剂1.0~1.5%、肠溶材料9.0~12.0%、防粘剂4.5~7.0%。本发明提供制备方法:先将布地奈德原料药经过气流粉碎机粉碎使原料药粒径高度接近,降低原料药在溶媒中的释放差异,缩小批间差异,再采用超声搅拌法,在微丸上药工序,将上药混悬液置于超声仪,使用搅拌器边搅拌边上药,使上药混悬液原料药分布均一,提高微丸含量均一性。本发明产品质量好,制备简单,宜于工业化生产,有较大的应用价值。
Drugs covered by this patent
- Pulmicort Respules (BUDESONIDE) · AstraZeneca K.K.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.